KNC Laboratories Co.,Ltd. (6568) Stock Price & Analysis

0 Followers

6568 Stock Chart & Stats

¥1,176.00-¥14.00(-1.18%)

At close: Nov 06 3:30 PM GMT+9

Day’s Range: JPY 1,119.00 - JPY 1,176.00
52-Week Range: JPY 1,060.00 - JPY 1,418.00
Previous Close: JPY 1,190.00
Volume: N/A
Average Volume (3M): 4,150
Market Cap: JPY 9.15B
Enterprise Value: JPY 11.01B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 11.3
Beta: 0.59
Next Earnings: Nov 13, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: Mar 30, 2027
Dividend Yield: 2.81%

Bulls Say, Bears Say

Bulls Say

2026 Revenue Rebound

The return to double-digit revenue growth indicates renewed demand or improved commercial execution after the 2025 decline. Sustained top-line recovery could support operating scale, although future benefit depends on restoring margins.

Strong Balance Sheet

Steady equity growth and historically moderate leverage provide financial resilience and borrowing capacity. This capitalization can help the company fund operations and investment through weaker profit periods without excessive balance-sheet strain.

Improved Operating Cash Flow

The recovery in operating cash flow suggests that underlying cash generation improved despite recent earnings pressure. If maintained, stronger operating inflows could restore funding flexibility and help finance investment with less reliance on additional debt.

Bears Say

Material Profitability Compression

Lower operating profit and net income indicate that the recent revenue rebound has not yet translated into comparable earnings power. Persistent pressure from pricing, product mix, or input costs could limit returns and weaken the durability of growth.

Two Years Of Negative Free Cash Flow

Repeatedly negative free cash flow reduces flexibility for debt reduction, shareholder distributions, and self-funded expansion. Even with improved operating cash flow, continued investment needs or weak cash conversion could require external financing.

Recent Debt Build

Although leverage remains manageable, rising debt increases financial risk while margins and free cash flow are under pressure. If earnings recovery stalls, additional borrowing could constrain investment capacity and raise dependence on balance-sheet funding.

6568 FAQ

What was KNC Laboratories Co.,Ltd.’s price range in the past 12 months?

KNC Laboratories Co.,Ltd. lowest stock price was ¥1060.00 and its highest was ¥1418.00 in the past 12 months.

What is KNC Laboratories Co.,Ltd.’s market cap?

KNC Laboratories Co.,Ltd.’s market cap is ¥9.15B.

When is KNC Laboratories Co.,Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were KNC Laboratories Co.,Ltd.’s earnings last quarter?

KNC Laboratories Co.,Ltd. released its earnings results on Aug 07, 2026. The company reported ¥5.3 earnings per share for the quarter.

Is KNC Laboratories Co.,Ltd. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does KNC Laboratories Co.,Ltd. pay dividends?

KNC Laboratories Co.,Ltd. pays a Semiannually dividend of ¥17 which represents an annual dividend yield of 2.81%. See more information on KNC Laboratories Co.,Ltd. dividends here

What is KNC Laboratories Co.,Ltd.’s EPS estimate?

KNC Laboratories Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does KNC Laboratories Co.,Ltd. have?

KNC Laboratories Co.,Ltd. has 7,779,900 shares outstanding.

What happened to KNC Laboratories Co.,Ltd.’s price movement after its last earnings report?

KNC Laboratories Co.,Ltd. reported an EPS of ¥5.3 in its last earnings report. Following the earnings report the stock price went up 0.079%.

Which hedge fund is a major shareholder of KNC Laboratories Co.,Ltd.?

Currently, no hedge funds are holding shares in JP:6568

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description